While evidence triangulation and complementary analytical methods are well established, there is much less discussion about how they should be integrated and interpreted as a coherent body of evidence.
Using practical examples from comparative effectiveness research, this webinar explores the challenge of causal evidence triangulation for pharmacoepidemiology. Specifically, how combining complementary study designs and targeted sensitivity analyses produces robust, regulator-ready causal interpretations in real-world evidence studies.
Attendees will be able to:
- Explain the principles of evidence triangulation and its role in strengthening causal interpretation
- Describe how complementary study designs and analytical approaches each contribute distinct strengths and limitations through different assumptions and potential source of bias
- Interpret agreement and disagreement between methodological approaches as part of transparent causal interpretation credibility of the evidence
Presenters:
- Premysl Velek, MSc, Data Scientist, PHARMO, part of Lumanity
- Moderator: Deborah Layton, PhD, Chief Scientific Officer, PHARMO, part of Lumanity